AVROBIO
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 May 2023)
What this means for you
This application is over — abandoned 22 May 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88656805
- Mark type
- Stylized text
- Filed
- 16 Oct 2019
- Published for opposition
- 25 Feb 2020
- Abandoned
- 22 May 2023
- Attorney of record
- Michael J. Belliveau
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of genetic diseases; gene therapy products, namely, vectors and engineered cells for the treatment of genetic diseases
Owner
- AVROBIO, Inc., Cambridge, MA, US
- AVROBIO, Inc., Cambridge, MA, US
Prosecution history
- 22 May 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 May 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Nov 2022 — SOU EXTENSION 5 GRANTED
- 20 Oct 2022 — SOU EXTENSION 5 FILED
- 31 Oct 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 23 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Apr 2022 — SOU EXTENSION 4 GRANTED
- 21 Apr 2022 — SOU EXTENSION 4 FILED
- 21 Apr 2022 — SOU TEAS EXTENSION RECEIVED
- 21 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Oct 2021 — SOU EXTENSION 3 GRANTED
- 19 Oct 2021 — SOU EXTENSION 3 FILED
- 19 Oct 2021 — SOU TEAS EXTENSION RECEIVED